# Mesenteric Ischemia: A Comprehensive Clinical Guide

**Book Chapter for Surgical Residents and Practicing Vascular Surgeons**

---

> **Based on AKUs**: `health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia/`
> **Version**: 1.0
> **Last Updated**: 2026-01-04
> **Audience**: Medical professionals, surgical residents, vascular surgery fellows
> **Reading Time**: ~45 minutes
> **License**: CC-BY-4.0

---

## Table of Contents

1. [Introduction](#introduction)
2. [Mesenteric Vascular Anatomy](#mesenteric-vascular-anatomy)
3. [Pathophysiology](#pathophysiology)
4. [Classification and Types](#classification-and-types)
5. [Clinical Presentation](#clinical-presentation)
6. [Diagnostic Approach](#diagnostic-approach)
7. [Imaging Modalities](#imaging-modalities)
8. [Treatment Algorithms](#treatment-algorithms)
9. [Surgical Techniques](#surgical-techniques)
10. [Endovascular Interventions](#endovascular-interventions)
11. [Postoperative Care](#postoperative-care)
12. [Outcomes and Prognosis](#outcomes-and-prognosis)
13. [Special Considerations](#special-considerations)
14. [Case Studies](#case-studies)
15. [Summary and Key Points](#summary-and-key-points)
16. [References](#references)

---

## Introduction

Mesenteric ischemia represents one of the most challenging conditions in vascular surgery, characterized by inadequate blood flow to the intestines that can rapidly progress to irreversible bowel necrosis and death. The condition demands urgent recognition and treatment, as delays of even hours can dramatically impact patient survival.

### Historical Perspective

The recognition of mesenteric ischemia dates to the 1930s when surgeons first described the "syndrome of intestinal angina." Early mortality rates exceeded 90%, but advances in diagnostic imaging, surgical technique, and critical care have improved outcomes significantly—though mortality remains unacceptably high at 50-70% for acute presentations.

### The Clinical Challenge

The difficulty in managing mesenteric ischemia lies in:

1. **Non-specific presentation**: Early symptoms mimic common conditions
2. **Narrow therapeutic window**: Bowel becomes irreversibly damaged within 6-12 hours
3. **High-risk patient population**: Often elderly with multiple comorbidities
4. **Limited diagnostic biomarkers**: No "troponin equivalent" for bowel ischemia

![Figure 1: Overview of Mesenteric Vascular Supply](./images/image_001_20260104_204643_453303cb.png)
*Figure 1: Schematic overview of the mesenteric vascular anatomy showing the celiac trunk, superior mesenteric artery (SMA), and inferior mesenteric artery (IMA) with their key branches and territories.*

---

## Mesenteric Vascular Anatomy

A thorough understanding of mesenteric vascular anatomy is essential for diagnosing and treating mesenteric ischemia.

### Major Arterial Supply

#### Celiac Trunk
The celiac trunk arises from the anterior aorta at T12-L1 and supplies:
- **Left gastric artery**: Stomach and distal esophagus
- **Splenic artery**: Spleen, pancreas tail, stomach
- **Common hepatic artery**: Liver, gallbladder, duodenum, stomach, pancreas

#### Superior Mesenteric Artery (SMA)
The SMA is the principal artery supplying the majority of the small intestine and right colon:
- Originates from the anterior aorta at L1
- **Branches**:
  - Inferior pancreaticoduodenal artery
  - Middle colic artery
  - Right colic artery
  - Ileocolic artery
  - Jejunal and ileal branches (15-18 branches)

![Figure 2: SMA Anatomy and Branches](./images/image_002_20260104_204653_7733d603.png)
*Figure 2: Detailed anatomy of the superior mesenteric artery showing all major branches and their territories. Note the arcade system providing collateral circulation.*

#### Inferior Mesenteric Artery (IMA)
The IMA supplies the left colon, sigmoid, and upper rectum:
- Originates at L3
- **Branches**:
  - Left colic artery
  - Sigmoid arteries
  - Superior rectal artery

### Collateral Circulation

The intestinal blood supply features extensive collateral networks:

1. **Marginal artery of Drummond**: Connects SMA and IMA territories along the mesenteric border
2. **Arc of Riolan (meandering mesenteric artery)**: Direct connection between proximal SMA and IMA
3. **Pancreaticoduodenal arcades**: Connect celiac and SMA territories
4. **Hemorrhoidal connections**: Connect IMA to internal iliac via rectal vessels

![Figure 3: Collateral Pathways](./images/image_003_20260104_204653_cbbd212c.png)
*Figure 3: Major collateral pathways between the three mesenteric arterial territories. Understanding these pathways is crucial for predicting ischemic zones and planning revascularization.*

### Venous Drainage

The mesenteric venous system parallels the arterial supply:
- **Superior mesenteric vein (SMV)**: Drains territories supplied by SMA
- **Inferior mesenteric vein (IMV)**: Drains left colon and rectum
- **Portal vein**: Formed by junction of SMV and splenic vein

---

## Pathophysiology

### Mechanisms of Ischemic Injury

The intestinal mucosa has one of the highest oxygen consumption rates in the body, making it exquisitely sensitive to hypoperfusion. Ischemic injury progresses through predictable phases:

#### Phase 1: Hypoxia (0-30 minutes)
- Depletion of cellular ATP stores
- Switch to anaerobic metabolism
- Lactate accumulation
- Reversible cellular dysfunction

#### Phase 2: Early Injury (30 minutes - 2 hours)
- Mucosal epithelial cell detachment
- Increased intestinal permeability
- Bacterial translocation begins
- Still potentially reversible with reperfusion

#### Phase 3: Established Injury (2-6 hours)
- Full-thickness mucosal necrosis
- Significant bacterial translocation
- Systemic inflammatory response activation
- Irreversible without resection in some segments

#### Phase 4: Transmural Necrosis (>6 hours)
- Complete bowel wall necrosis
- Perforation risk
- Septic shock
- Multi-organ failure

![Figure 4: Pathophysiology Timeline](./images/image_004_20260104_204651_784a880a.png)
*Figure 4: Timeline of ischemic injury progression showing cellular and tissue-level changes. The "golden window" for intervention is typically within the first 2-6 hours.*

### Reperfusion Injury

Paradoxically, restoration of blood flow can exacerbate tissue damage through:
- **Reactive oxygen species (ROS) generation**
- **Neutrophil activation and infiltration**
- **Complement cascade activation**
- **Further endothelial damage**

This "second hit" can convert reversible injury to irreversible necrosis.

---

## Classification and Types

Mesenteric ischemia is classified by onset (acute vs. chronic) and etiology:

### Acute Mesenteric Ischemia (AMI)

| Type | Prevalence | Mechanism | Key Features |
|------|------------|-----------|--------------|
| **Arterial Embolism** | 40-50% | Cardiac source (AF, MI, endocarditis) | Sudden onset, "pain out of proportion to exam" |
| **Arterial Thrombosis** | 20-30% | Atherosclerosis, dissection | History of chronic symptoms, postprandial pain |
| **Venous Thrombosis (MVT)** | 10-15% | Hypercoagulable states, portal HTN | Subacute presentation, abdominal distension |
| **Non-occlusive (NOMI)** | 20-30% | Splanchnic vasoconstriction | ICU patients, vasopressors, cardiac surgery |

![Figure 5: AMI Classification](./images/image_005_20260104_204647_6c6d4eae.png)
*Figure 5: Classification of acute mesenteric ischemia by etiology. Understanding the mechanism guides both diagnosis and treatment approach.*

### Chronic Mesenteric Ischemia (CMI)

CMI results from progressive atherosclerotic stenosis of mesenteric vessels. The classic triad:
1. **Postprandial abdominal pain** ("intestinal angina")
2. **Food fear** (sitophobia) leading to weight loss
3. **Evidence of generalized atherosclerosis**

Typically requires stenosis of 2-3 vessels before symptoms develop due to robust collateral circulation.

### Colonic Ischemia

The most common form of intestinal ischemia, typically affecting:
- **Watershed areas**: Splenic flexure, rectosigmoid junction
- **Low-flow states**: Hypotension, cardiac surgery, marathon running
- **Usually non-occlusive** and self-limiting

---

## Clinical Presentation

### Acute Mesenteric Ischemia

The classic presentation of AMI is **"pain out of proportion to physical examination"**—severe abdominal pain with minimal findings on palpation. However, this "textbook" presentation occurs in only 50-75% of cases.

#### Symptoms by Etiology

**Arterial Embolism:**
- Sudden onset of severe periumbilical pain
- Often associated with nausea, vomiting, diarrhea (initially)
- May have recent cardiac event or arrhythmia

**Arterial Thrombosis:**
- History of chronic postprandial pain
- Acute exacerbation of chronic symptoms
- Weight loss, malnutrition common

**Mesenteric Venous Thrombosis:**
- Subacute onset over days to weeks
- Abdominal distension
- Bloody diarrhea
- History of hypercoagulable state or portal hypertension

**NOMI:**
- Often intubated, sedated ICU patient
- Unexplained acidosis
- Abdominal distension
- High-dose vasopressor requirement

![Figure 6: Clinical Presentations](./images/image_006_20260104_204735_9f6cc71f.png)
*Figure 6: Comparison of clinical presentations across the four main types of acute mesenteric ischemia.*

### Physical Examination Findings

**Early:**
- Minimal to no tenderness despite severe pain
- Normal or hyperactive bowel sounds
- No peritoneal signs

**Late (with bowel necrosis):**
- Peritonitis with guarding and rebound
- Absent bowel sounds
- Hemodynamic instability
- Shock

### Laboratory Findings

No laboratory test is diagnostic for mesenteric ischemia, but abnormalities support the diagnosis:

| Test | Finding | Significance |
|------|---------|--------------|
| **Lactate** | Elevated | Non-specific but correlates with severity |
| **D-dimer** | Elevated | High sensitivity, low specificity |
| **Leukocytosis** | Elevated WBC | Non-specific |
| **Metabolic acidosis** | Low pH, high anion gap | Late finding, poor prognosis |
| **Amylase/Lipase** | May be elevated | Can mimic pancreatitis |
| **I-FABP** (investigational) | Elevated | Promising biomarker, not widely available |

---

## Diagnostic Approach

### High Clinical Suspicion

The key to early diagnosis is maintaining a high index of suspicion in at-risk patients:
- Atrial fibrillation
- Recent MI or cardiac surgery
- Known atherosclerotic disease
- Hypercoagulable states
- ICU patients on vasopressors

### Diagnostic Algorithm

```
Suspected Mesenteric Ischemia
            │
            ▼
   Hemodynamically Stable?
       /           \
     Yes            No
      │              │
      ▼              ▼
   CT Angio     Emergent OR
      │         (resuscitation
      ▼          en route)
   Positive?
    /     \
  Yes     No
   │       │
   ▼       ▼
Confirm   Consider
and Plan  Alternative
   │      Diagnoses
   ▼
Treatment 
Algorithm
```

![Figure 7: Diagnostic Algorithm](./images/image_007_20260104_204736_c41a0954.png)
*Figure 7: Flowchart for the diagnostic approach to suspected mesenteric ischemia. CTA is the imaging modality of choice in stable patients.*

---

## Imaging Modalities

### CT Angiography (CTA)

CTA is the **gold standard** for diagnosing acute mesenteric ischemia with sensitivity of 93-96% and specificity of 94-100%.

#### Key CTA Findings

**Arterial Occlusion:**
- Filling defect or abrupt cutoff in mesenteric vessels
- Absence of contrast enhancement distal to occlusion

**Venous Thrombosis:**
- Thrombus in SMV or portal vein
- Bowel wall thickening
- Mesenteric edema ("misty mesentery")

**Bowel Wall Changes:**
- **Thin, paper-like wall**: Arterial etiology
- **Thick, edematous wall**: Venous or NOMI etiology
- **Pneumatosis intestinalis**: Gas within bowel wall (late finding)
- **Portal venous gas**: Ominous sign indicating necrosis

![Figure 8: CTA Findings](./images/image_008_20260104_204740_3baf5f41.png)
*Figure 8: Representative CT angiography images demonstrating key findings in mesenteric ischemia: (A) SMA occlusion, (B) SMV thrombosis, (C) pneumatosis intestinalis, (D) portal venous gas.*

### Duplex Ultrasound

Limited role in acute setting but useful for:
- Chronic mesenteric ischemia screening
- Follow-up after revascularization
- Patients unable to receive contrast

**Criteria for significant stenosis:**
- Peak systolic velocity >275 cm/s in SMA
- End-diastolic velocity >45 cm/s in SMA

### Conventional Angiography

Largely replaced by CTA but retains role when:
- Endovascular intervention planned
- CTA equivocal
- Therapeutic intervention immediately planned

---

## Treatment Algorithms

### General Principles

1. **Time is bowel**: Minimize delays at every step
2. **Adequate resuscitation** before intervention
3. **Anticoagulation** for all types (unless contraindicated)
4. **Source control** of necrotic bowel
5. **Multidisciplinary approach**: Surgery, IR, ICU

### Acute Arterial Occlusion

```
Acute Arterial Mesenteric Ischemia
            │
            ▼
   Immediate Anticoagulation
            │
            ▼
   Hemodynamic Optimization
            │
            ▼
    Signs of Peritonitis?
       /           \
     Yes            No
      │              │
      ▼              ▼
   Emergent      Endovascular
     OR          Candidate?
      │           /     \
      ▼         Yes     No
  Open Surgical   │      │
  Revascularization ▼   ▼
  + Resection   Endovascular  Open Surgical
  as needed     Thrombectomy  Revascularization
                ± Thrombolysis
```

![Figure 9: Treatment Algorithm - Arterial](./images/image_009_20260104_204746_5b23b24a.png)
*Figure 9: Treatment algorithm for acute arterial mesenteric ischemia. The decision between open and endovascular approaches depends on patient stability, anatomy, and institutional expertise.*

### Mesenteric Venous Thrombosis

- **Anticoagulation** is primary treatment
- Surgical intervention only for peritonitis/bowel necrosis
- Consider thrombolysis for extensive SMV/portal thrombosis
- Long-term anticoagulation required

### Non-Occlusive Mesenteric Ischemia (NOMI)

- **Treat underlying cause**: Optimize cardiac output
- **Wean vasopressors** if possible
- **Papaverine infusion** via SMA catheter (historically)
- **Surgical exploration** if peritonitis develops
- Highest mortality of all types

---

## Surgical Techniques

### Open Surgical Revascularization

#### SMA Embolectomy

Indicated for proximal SMA emboli without extensive thrombosis:

1. Midline laparotomy
2. Expose SMA at root of mesentery (lift transverse mesocolon)
3. Transverse arteriotomy proximal to middle colic artery
4. Passage of Fogarty catheter (3-4 Fr) proximally and distally
5. Extraction of embolic material
6. Arteriotomy closure (primary or patch)
7. Assessment of bowel viability

![Figure 10: SMA Exposure](./images/image_010_20260104_204756_1aa76a10.png)
*Figure 10: Surgical exposure of the superior mesenteric artery at the root of the mesentery. Key landmarks and relationship to surrounding structures are highlighted.*

#### SMA Bypass

Indicated for atherosclerotic thrombosis or when embolectomy unsuccessful:

**Inflow options:**
- Supraceliac aorta (antegrade bypass)
- Infrarenal aorta
- Common iliac artery (retrograde bypass)

**Conduit:**
- Saphenous vein (preferred for infected field)
- PTFE (if no contamination risk)

**Technique:**
1. Supraceliac aortic exposure via left medial visceral rotation
2. End-to-side proximal anastomosis
3. Tunnel graft through small bowel mesentery
4. End-to-end or end-to-side SMA anastomosis

![Figure 11: SMA Bypass Configurations](./images/image_011_20260104_204817_fb26b39e.png)
*Figure 11: Configuration options for SMA bypass grafting: (A) Antegrade from supraceliac aorta, (B) Retrograde from common iliac artery. The antegrade configuration is preferred when feasible.*

### Bowel Resection

#### Indications
- Obvious necrosis (black, non-viable bowel)
- Perforation
- Questionable viability after revascularization

#### Viability Assessment

**Clinical criteria:**
- Color (pink vs. dusky/black)
- Peristalsis
- Arterial bleeding from cut edges
- Mesenteric vessel pulsation

**Adjuncts:**
- Fluorescein with Wood's lamp
- Doppler assessment
- Indocyanine green (ICG) angiography

#### Second-Look Laparotomy

Planned re-exploration at 24-48 hours when:
- Marginal viability of remaining bowel
- Hemodynamic instability limiting complete assessment
- Extensive ischemia requiring damage control approach

![Figure 12: Bowel Viability Assessment](./images/image_012_20260104_204831_ba082831.png)
*Figure 12: Visual assessment of bowel viability. Color spectrum from clearly viable (pink) to clearly non-viable (black) with zones of uncertain viability requiring additional assessment techniques.*

---

## Endovascular Interventions

### Catheter-Directed Thrombolysis

Indicated for acute thrombosis or embolism without peritonitis:
- SMA catheterization via femoral approach
- tPA infusion (0.5-1.0 mg/hr)
- Repeat angiography every 6-12 hours
- Adjunctive mechanical thrombectomy as needed

### Percutaneous Mechanical Thrombectomy

Newer devices allow rapid clot removal:
- AngioJet rheolytic thrombectomy
- Aspiration thrombectomy
- Combined pharmacomechanical approaches

### Stenting

Role for underlying atherosclerotic stenosis after thrombectomy:
- Self-expanding or balloon-expandable stents
- Primary patency 80-90% at 1 year
- Consider in patient with CMI progressing to acute

![Figure 13: Endovascular Options](./images/image_013_20260104_204826_9ea183f2.png)
*Figure 13: Endovascular treatment options for mesenteric ischemia: (A) Catheter-directed thrombolysis setup, (B) Mechanical thrombectomy device, (C) SMA stenting after revascularization.*

---

## Postoperative Care

### Critical Care Management

**Hemodynamic Monitoring:**
- Arterial line for continuous BP monitoring
- Central venous access
- Consider PA catheter or echocardiography for cardiac output assessment

**Fluid Resuscitation:**
- Often massive third-spacing
- Target MAP >65-70 mmHg
- Avoid excessive vasopressor use (exacerbates NOMI)

**Laboratory Monitoring:**
- Serial lactate (trending more important than absolute value)
- Acidosis correction
- Electrolyte management (especially potassium)

### Anticoagulation

- **Unfractionated heparin** initially (adjustable, reversible)
- Transition to **warfarin** or **DOAC** for long-term
- Duration depends on etiology:
  - Atrial fibrillation: Lifelong
  - Hypercoagulable state: Lifelong or until resolved
  - Atherosclerotic: Case-by-case

### Nutritional Support

- **NPO** initially with TPN as needed
- Slow advancement of enteral nutrition once bowel function returns
- Watch for short bowel syndrome if extensive resection

---

## Outcomes and Prognosis

### Mortality

Despite advances, mesenteric ischemia carries high mortality:

| Type | Mortality |
|------|-----------|
| Arterial embolism | 50-70% |
| Arterial thrombosis | 70-90% |
| MVT | 20-40% |
| NOMI | 70-90% |

### Predictors of Poor Outcome

- Delay in diagnosis >24 hours
- Bowel necrosis at presentation
- Need for bowel resection
- Multiorgan failure
- Advanced age (>70 years)
- Comorbid cardiac disease

### Long-Term Complications

**Short Bowel Syndrome:**
- Results from extensive resection (>200 cm small bowel)
- Requires TPN, potential intestinal transplant
- Significantly impacts quality of life

**Recurrent Ischemia:**
- Risk of repeat events, especially with AF
- Close monitoring, optimal anticoagulation essential

![Figure 14: Outcomes by Type](./images/image_014_20260104_204826_bd71ef24.png)
*Figure 14: Comparative outcomes across different types of mesenteric ischemia. Early diagnosis and intervention are the most modifiable factors affecting survival.*

---

## Special Considerations

### Elderly Patients

- Often present atypically (confusion, falls, sepsis without localizing symptoms)
- Lower threshold for imaging
- Consider goals of care discussions early
- Frailty assessment before major surgery

### Post-Cardiac Surgery

- High risk for NOMI
- Monitor for unexplained acidosis
- Low threshold for CT if abdominal distension develops
- Vasoactive medication adjustments critical

### Pediatric Presentations

- Rare but can occur with:
  - Midgut volvulus (neonates)
  - Intussusception
  - Hypercoagulable disorders
- Different etiologic spectrum

---

## Case Studies

### Case 1: Classic Arterial Embolism

**Presentation:** 72-year-old woman with atrial fibrillation (not anticoagulated) presents with sudden onset of severe periumbilical pain for 4 hours. Minimal tenderness on exam. Lactate 4.2 mmol/L.

**Imaging:** CTA shows abrupt cutoff of SMA 3 cm from origin with no distal filling.

**Management:** 
1. Immediate heparinization
2. Emergent laparotomy
3. SMA embolectomy with extraction of large thrombus
4. 60 cm of dusky jejunum observed—viability uncertain
5. Warm packs applied, bowel reassessed after 15 minutes
6. Color and peristalsis return—no resection needed
7. Second-look laparotomy at 48 hours—viable bowel

**Outcome:** Full recovery, discharged on warfarin.

### Case 2: Chronic Mesenteric Ischemia with Acute Decompensation

**Presentation:** 65-year-old smoker with 6-month history of postprandial pain and 25 lb weight loss. Now presenting with acute severe abdominal pain.

**Imaging:** CTA shows high-grade stenosis of celiac trunk (occluded), SMA (95% stenosis with superimposed thrombus), and IMA (occluded).

**Management:**
1. Attempt at endovascular intervention—unable to cross lesion
2. Emergent open bypass: Supraceliac aorta to SMA
3. 30 cm of non-viable ileum resected with primary anastomosis

**Outcome:** Prolonged ICU course, eventually discharged. Surveillance duplex at 6 months shows patent graft.

---

## Summary and Key Points

### Critical Takeaways

1. **Maintain high suspicion** in at-risk patients with acute abdominal pain
2. **"Pain out of proportion to exam"** is the classic but not universal finding
3. **CTA is the diagnostic modality of choice**—obtain early
4. **Time is bowel**—minimize delays at every step
5. **Anticoagulation** should be started immediately in most cases
6. **Endovascular vs. open** approach depends on clinical status and anatomy
7. **Second-look laparotomy** is crucial when bowel viability is uncertain
8. **Multidisciplinary team** involvement improves outcomes

### Algorithm Summary

![Figure 15: Summary Algorithm](./images/image_015_20260104_204842_410a3f91.png)
*Figure 15: Comprehensive summary algorithm for the diagnosis and management of acute mesenteric ischemia. This flowchart integrates key decision points from recognition through treatment.*

---

## References

1. Bala M, Kashuk J, Moore EE, et al. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. *World J Emerg Surg*. 2017;12:38.

2. Clair DG, Beach JM. Mesenteric Ischemia. *N Engl J Med*. 2016;374(10):959-968.

3. Tilsed JVT, Casamassima A, Kurihara H, et al. ESTES guidelines: acute mesenteric ischaemia. *Eur J Trauma Emerg Surg*. 2016;42(2):253-270.

4. Kärkkäinen JM, Acosta S. Acute mesenteric ischemia (part I)—Incidence, etiologies, and how to improve early diagnosis. *Best Pract Res Clin Gastroenterol*. 2017;31(1):15-25.

5. Björck M, Koelemay M, Acosta S, et al. Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS). *Eur J Vasc Endovasc Surg*. 2017;53(4):460-510.

6. Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: a clinical review. *Arch Intern Med*. 2004;164(10):1054-1062.

7. Acosta S, Björck M. Modern treatment of acute mesenteric ischaemia. *Br J Surg*. 2014;101(1):e100-108.

8. Brandt LJ, Boley SJ. AGA technical review on intestinal ischemia. *Gastroenterology*. 2000;118(5):954-968.

9. Cudnik MT, Darbha S, Jones J, Macedo J, Stockton SW, Hainer BL. The diagnosis of acute mesenteric ischemia: A systematic review and meta-analysis. *Acad Emerg Med*. 2013;20(11):1087-1100.

10. Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. *Br J Surg*. 2004;91(1):17-27.

---

## Appendix: Visual Reference Library

### Figure Index

| Figure | Description | AKU Reference |
|--------|-------------|---------------|
| Figure 1 | Mesenteric vascular overview | aku-004-mesenteric-arterial-anatomy |
| Figure 2 | SMA anatomy and branches | aku-004-mesenteric-arterial-anatomy |
| Figure 3 | Collateral pathways | aku-004-mesenteric-arterial-anatomy |
| Figure 4 | Ischemia timeline/pathophysiology | aku-005-ischemia-reperfusion-injury |
| Figure 5 | AMI classification | aku-002-acute-mesenteric-ischemia |
| Figure 6 | Clinical presentations | aku-010-clinical-presentations |
| Figure 7 | Diagnostic algorithm | aku-013-diagnostic-algorithm |
| Figure 8 | CTA findings | aku-015-cta-imaging |
| Figure 9 | Treatment algorithm (arterial) | aku-019-initial-resuscitation |
| Figure 10 | SMA surgical exposure | aku-021-open-surgical-revascularization |
| Figure 11 | SMA bypass configurations | aku-021-open-surgical-revascularization |
| Figure 12 | Bowel viability assessment | aku-026-bowel-viability-assessment |
| Figure 13 | Endovascular options | aku-022-endovascular-treatment |
| Figure 14 | Outcomes by type | aku-031-mortality-outcomes |
| Figure 15 | Summary algorithm | aku-001-mesenteric-ischemia-overview |

---

**Document Metadata:**
- **Version**: 1.0
- **Created**: 2026-01-04
- **Author**: WorldSMEGraphs Medical Content Team
- **Based on AKUs**: 55 mesenteric ischemia knowledge units
- **Peer Review Status**: Pending
- **License**: CC-BY-4.0
